Patents by Inventor Myriam Behgyn

Myriam Behgyn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • strain HD8: a mutant exhibiting constitutive pharyngeal pumping
    Patent number: 7030290
    Abstract: The invention provides methods of screening compounds for potential pharmacological activity using nematode worms, principally but not exclusively the nematode C. elegans. Specifically, the invention relates to the use of nematodes modified to have certain characteristics which provide advantages for compound screening, such as constitutive pharyngeal pumping, increased gut permeability or altered gut molecular transport. Methods for selecting suitably modified nematodes from a population of nematodes are also provided.
    Type: Grant
    Filed: August 11, 2003
    Date of Patent: April 18, 2006
    Assignee: Devgen NV
    Inventors: Philippe Verwaerde, Richard Feichtinger, Myriam Behgyn, Thierry Bogaert
  • Compound assay
    Publication number: 20040034880
    Abstract: The invention provides methods of screening compounds for potential pharmacological activity using nematode worms, principally but not exclusively the nematode C. elegans. Specifically, the invention relates to the use of nematodes modified to have certain characteristics which provide advantages for compound screening, such as constitutive pharyngeal pumping, increased gut permeability or altered gut molecular transport. Methods for selecting suitably modified nematodes from a population of nematodes are also provided.
    Type: Application
    Filed: August 11, 2003
    Publication date: February 19, 2004
    Applicant: Devgen NV
    Inventors: Philippe Verwaerde, Richard Feichtinger, Myriam Behgyn, Thierry Bogaert
  • Compound assay
    Patent number: 6664441
    Abstract: The invention provides methods of screening compounds for potential pharmacological activity using nematode worms, principally but not exclusively the nematode C. elegans. Specifically, the invention relates to the use of nematodes modified to have certain characteristics which provide advantages for compound screening, such as constitutive pharyngeal pumping, increased gut permeability or altered gut molecular transport. Methods for selecting suitably modified nematodes from a population of nematodes are also provided.
    Type: Grant
    Filed: April 14, 2000
    Date of Patent: December 16, 2003
    Assignee: Devgen NV
    Inventors: Philippe Verwaerde, Richard Feichtinger, Myriam Behgyn, Thierry Bogaert
  • Compound screening method
    Publication number: 20030154501
    Abstract: The invention provides methods for screening of chemical substances with potential pharmacological activity using nematode worms such as Caenorhabditis elegans, Specifically, the invention relates to methods adapted for high-throughput screening which are performed in a multi-well plate format.
    Type: Application
    Filed: August 7, 2002
    Publication date: August 14, 2003
    Applicant: Devgen, N.V.
    Inventors: Philippe Verwaerde, Thierry Bogaert, Christ Platteeuw, Gwladys Cuvillier, Myriam Behgyn, Richard Feichtinger